BLACR
Bellevue Life Sciences Acquisition Corp. Rights
BLACR
BLACR
Delisted
BLACR was delisted on the 14th of February, 2025.
28 hedge funds and large institutions have $838K invested in Bellevue Life Sciences Acquisition Corp. Rights in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
Holders
28
Holders Change
+4
Holders Change %
+16.67%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
2
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
1
JPMorgan Chase & Co
New York
|
$45K |
2 |
2
Walleye Capital
New York
|
$25.2K |
3 |
HCM
3
Highbridge Capital Management
New York
|
$125K |
4 |
4
Walleye Trading
New York
|
$14.2K |
5 |
CS
5
Clear Street
New York
|
$28.7K |